Efficacy of Amicar for Children Having Craniofacial Surgery
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Amicar (ε-aminocaproic acid) is effective
in reducing blood loss in children undergoing craniofacial reconstruction surgery.
The investigators hypothesize that Amicar will decrease intraoperative blood loss and
decrease the need for perioperative blood product administration in children undergoing
craniofacial surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Children's National Research Institute Srijaya K. Reddy, MD, MBA